Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
3.
Cutis ; 111(2): 82-83, 2023 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-37075178

RESUMO

Achieving hemostasis in cutaneous surgery on bony or irregular surfaces can be challenging; typical pressure dressings that act by mechanical occlusion with petrolatum gauze can be inadequate. We offer the use of bone wax as a practical hemostatic agent that can be (1) molded to provide ideal occlusion and pressure without adhering to wound surfaces and (2) painlessly and simply removed.


Assuntos
Hemostáticos , Humanos , Hemostáticos/uso terapêutico , Ceras , Hemostasia , Palmitatos
4.
JAMA Dermatol ; 159(4): 450-451, 2023 04 01.
Artigo em Inglês | MEDLINE | ID: mdl-36811868

RESUMO

A woman in her 80s initially presented with numerous, primarily photodistributed, crusted, and ulcerated plaques of the trunk and extremities and a medical history of essential thrombocytosis treated with hydroxyurea for 14 years. What is your diagnosis?


Assuntos
Extremidades , Hidroxiureia , Humanos , Hidroxiureia/efeitos adversos
5.
J Am Acad Dermatol ; 86(6): 1246-1257, 2022 06.
Artigo em Inglês | MEDLINE | ID: mdl-34890701

RESUMO

BACKGROUND: The role of adjuvant radiotherapy for high-risk cutaneous squamous cell carcinomas after surgery with negative margins is unclear. OBJECTIVE: To conduct a systematic review and meta-analysis examining the risk of poor outcomes for patients treated with surgery alone versus surgery and adjuvant radiotherapy. METHODS: A comprehensive search of articles was executed in PubMed, Embase, and the Cochrane Database. Random-effected meta-analyses were conducted. RESULTS: Thirty-three studies comprising 3867 high-risk cutaneous squamous cell carcinomas were included. There were no statistically significant differences in poor outcomes between the surgery only group and surgery with adjuvant radiotherapy group. Estimates for local recurrence for the surgery alone group versus the surgery with adjuvant radiotherapy group were 15.2% (95% confidence interval [CI], 6.3%-27%) versus 8.8% (95% CI, 1.6%-20.9%); for regional metastases, 11.5% (95% CI, 7.2%-16.7%) versus 4.4% (95% CI, 0%-18%); for distant metastases, 2.6% (95% CI, 0.6%-6%) versus 1.7% (95% CI, 0.2%-4.5%); and for disease-specific deaths, 8.2% (95% CI, 1.2%-20.6%) versus 19.7% (95% CI, 3.8%-43.7%), respectively. LIMITATIONS: Retrospective nature of most studies with the lack of sufficient patient-specific data. CONCLUSIONS: For patients with high-risk cutaneous squamous cell carcinomas treated with margin-negative resection, there were no significant differences in poor outcomes between the surgery only group and the surgery with adjuvant radiotherapy group. Randomized controlled trials are necessary to define the benefit of adjuvant radiotherapy in this setting.


Assuntos
Carcinoma de Células Escamosas , Neoplasias Cutâneas , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/radioterapia , Carcinoma de Células Escamosas/cirurgia , Humanos , Margens de Excisão , Radioterapia Adjuvante , Estudos Retrospectivos , Neoplasias Cutâneas/patologia , Neoplasias Cutâneas/radioterapia , Neoplasias Cutâneas/cirurgia
7.
J Vasc Surg Venous Lymphat Disord ; 9(4): 1031-1040, 2021 07.
Artigo em Inglês | MEDLINE | ID: mdl-34144767

RESUMO

BACKGROUND: Superficial venous disease of the lower extremity has a significant impact on quality of life. Both truncal and tributary vein reflux contribute to this disease process. Endovenous foam sclerotherapy is a widely used technique throughout the world for the management of superficial venous reflux and ultrasound guidance improves its safety and efficacy. METHODS: A PubMed search for ultrasound-guided foam sclerotherapy (UGFS) was conducted and all abstracts were reviewed to identify clinical trials and systematic reviews for a full-text analysis. Additional articles were also identified through searching the references of the selected studies. RESULTS: The production of foam for sclerotherapy in a 1:3 or 1:4 ratio of air to sclerosant is optimal in a low silicone, low-volume syringe system. Physiologic gas may decrease any side effects, with the trade-off of decreased foam stability. Proper technique with appropriate sterility and cleansing protocols are paramount for safe and effective treatment. The technical success of UGFS for great saphenous vein disease is inferior to endothermal and surgical modalities and retreatment is more common. However, the clinical improvement in patient-reported quality of life is similar between these three modalities. When used for tributary veins in combination with endothermal approaches of the truncal veins, UGFS has high rates of success with excellent patient satisfaction. UGFS has demonstrated an excellent safety profile comparable with or superior to other modalities. CONCLUSIONS: With proper technique, UGFS is safe and effective for the management of superficial venous disease.


Assuntos
Extremidade Inferior/irrigação sanguínea , Escleroterapia/métodos , Insuficiência Venosa/terapia , Humanos , Extremidade Inferior/diagnóstico por imagem , Doenças do Sistema Nervoso/etiologia , Qualidade de Vida , Soluções Esclerosantes/administração & dosagem , Escleroterapia/efeitos adversos , Meias de Compressão , Ultrassonografia , Varizes/terapia , Insuficiência Venosa/diagnóstico por imagem , Trombose Venosa/etiologia
10.
Cutis ; 106(2): E8-E11, 2020 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-32941565

RESUMO

This case series discusses 3 patients with long-standing eczematous or psoriasiform dermatitis, demonstrated by multiple biopsies. Following off-label treatment with dupilumab, all 3 patients had clinical expansion of disease, with histopathologic features consistent with cutaneous T-cell lymphoma (CTCL) on subsequent biopsy. We postulate that this expansion likely was secondary to an exacerbation of extant CTCL following exposure to dupilumab. A proposed mechanism of promotion of CTCL is based on the functional increase in IL-13 available for binding at the upregulated IL-13 receptor (IL-13R) α2 site on cells, following blockade of the α1 receptor with dupilumab. This progression merits further investigation.


Assuntos
Anticorpos Monoclonais Humanizados/administração & dosagem , Dermatite/tratamento farmacológico , Eczema/tratamento farmacológico , Linfoma Cutâneo de Células T/diagnóstico , Anticorpos Monoclonais Humanizados/efeitos adversos , Biópsia , Dermatite/patologia , Progressão da Doença , Eczema/patologia , Feminino , Humanos , Interleucina-13/imunologia , Linfoma Cutâneo de Células T/etiologia , Linfoma Cutâneo de Células T/patologia , Masculino , Pessoa de Meia-Idade , Uso Off-Label , Psoríase/tratamento farmacológico , Psoríase/patologia
12.
Skinmed ; 15(4): 311-313, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28859749

RESUMO

A 64-year-old white woman was originally diagnosed with histiocytic lymphoma in 1977. She had bilateral lymph node biopsies of the groin, chemotherapy, and radiation therapy after her diagnosis had been confirmed pathologically. She was treated with prednisone and vincristine.


Assuntos
Linfangiectasia/etiologia , Linfangioma/cirurgia , Neoplasias Vulvares/cirurgia , Vulvectomia/efeitos adversos , Feminino , Humanos , Pessoa de Meia-Idade , Remissão Espontânea , Vulvectomia/métodos
13.
Dermatol Online J ; 23(2)2017 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-28329499

RESUMO

This report details an acral melanoma in-situ on theright plantar foot that was successfully treated withMohs micrographic surgery and secondary intentionwound healing.


Assuntos
, Melanoma/cirurgia , Neoplasias Cutâneas/cirurgia , Cicatrização , Idoso , Feminino , Humanos , Melanoma/patologia , Cirurgia de Mohs , Estadiamento de Neoplasias , Neoplasias Cutâneas/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA